Devyser Diagnostics AB
DVYSRStockST
89.70 ▼ 0.77%
Jun 12, 2026
D
Devyser Diagnostics AB
89.70 ▼ 0.77%
Jun 12, 2026
DVYSRStockST

About the company

Devyser Diagnostics AB (publ) provides diagnostic kits and advanced analysis services for clinical genetics and post-transplantation laboratories in Sweden, rest of Europe, the Middle East, and Africa. It offers kits and reagents, such as post-transplantation, thalassemia, fetal RHD screening NIPT, Cystic fibrosis cardiovascular diseases, male infertility, rapid aneuploidy analysis, accessories, hereditary cancer, and transfusion medicine products; and Amplicon Suite and Advyser for cloud-based software solutions for data analysis and the interpretation of test results. The company was incorporated in 2004 and is headquartered in Årsta, Sweden.

Arberion
Loading market data